The impacts of canine-assisted therapy on combat Veterans with post-traumatic stress disorder

Abstract: The purpose of this study was to examine the impact of canine-assisted therapy (CAT) on combat-related posttraumatic stress disorder (PTSD) by conducting a systematic literature review with qualitative analysis. The Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) framework was used to establish criteria for selecting relevant peer-reviewed research articles as the primary source of information for the review. NVivo 14 software was employed to create categorical themes and facilitate the comprehensive analysis of qualitative and quantitative data, resulting in the development of a systematic literature review. A sample of 19 articles was selected from 88 articles obtained from various library and Internet databases. The formulation of research questions facilitated an in-depth examination of the effects of CAT and similar therapies on combat-related PTSD, focusing on the extent to which these alternative treatment methods have contributed to symptom improvement. Multiple studies have found evidence supporting the positive effects of pairing veterans with service dogs. These studies show veterans experience a decrease in perceived stress and symptoms related to traumatic stress when they have a service dog. Service dogs also help veterans feel less isolated and encourage them to engage more socially. Service dogs contribute to a reduction in symptoms of PTSD and lower suicide ideation. Additionally, service dogs play a significant role in alerting and waking veterans from nightmares, as well as proactively disrupting symptoms associated with repeated trauma.

Read the full article
Report a problem with this article

Related articles

  • More for Researchers

    Risk of incident mild cognitive impairment and dementia soon after leaving incarceration among a US Veteran population

    Abstract: Objectives: Increasing numbers of older adults are reentering community following incarceration (i.e., reentry), yet risk of incident neurodegenerative disorders associated with reentry is unknown. Our objective was to determine association between reentry status (reentry vs never-incarcerated) and mild cognitive impairment (MCI) and/or dementia. Methods: This nationwide, longitudinal cohort study used linked Centers for Medicare & Medicaid Services and Veterans Health Administration data. Participants were aged 65 years or older who experienced reentry between October 1, 2012, and December 31, 2018, with no preincarceration MCI/dementia, compared with age-matched/sex-matched never-incarcerated veterans. MCI/dementia was defined by diagnostic codes. Fine-Gray proportional hazards models were used to examine association. Results: This study included 35,520 veterans, mean age of 70 years, and approximately 1% women. The reentry group (N = 5,920) had higher incidence of MCI/dementia compared with the never-incarcerated group (N = 29,600; 10.2% vs 7.2%; fully adjusted hazard ratio [aHR] 1.12; 95% CI 1.00-1.25). On further investigation, reentry was associated with increased risk of dementia with or without prior MCI diagnosis (aHR 1.21; 95% CI 1.06-1.39) but not MCI only. Discussion: Transition from incarceration to community increased risk of neurocognitive diagnosis. Findings indicate health/social services to identify and address significant cognitive deficits on late-life reentry. Limitations include generalizability to nonveterans.